Indian Institute Of Patent And Trademark warmly welcomes the Vidya Pratishthan,Baramati ,Pune as workshop partner in the sequel of promoting and spreading awareness of intellectual property rights(IPR) in India and abroad. The Vidya Pratishthan,a well renowned and reputed college in Pune and Maharashtra,is geared up to enhance the knowledge of IPR with IIPTA,having objective [...]
Indian Institute Of Patent And Trademark proudly announce the name of Arunai Engineering College,Tiruvannamalai, as workshop associate for role of intellectual property rights (IPR) in life science industries. Intellectual property (IP) contributes enormously to our national and state economies. Dozens of industries across our economy rely on the adequate enforcement of their patents, trademarks, [...]
Ericsson, world’s biggest telecom network equipment maker few months ago filed a patent infringement suit against Micromax, one of India’s largest domestic mobile handset manufacturers for allegedly infringing 8 of its telecom patents for a range of wireless technologies, including 3G, AMR and Edge The suit, filed at the Delhi High Court, involves a [...]
US Patent Application Number US 20130048020 A1 Titled “Oral care implement” sounds to be related to some dental implants or likewise but after going through the patent application one can easily find out that the patent application filed by Colgate-Palmolive Company revealed technology that would allow chemicals to be embedded into the heads of [...]
The World Intellectual Property Day is held on 26th April of every year. World Intellectual Property Organization (WIPO) marked26th April as World Intellectual Property Day in 2000 to “raise awareness of how patents, copyright, trademarks and designs impact on daily life” and “to celebrate creativity, and the contribution made by creators and innovators to [...]
India’s Supreme Court has set an important precedent in refusing to grant a patent to Novartis for an updated version of its cancer drug Glivec. The verdict will allow generic drug makers within the country to continue selling cheap versions of the drug, which is used to treat chronic myeloid leukemia and other cancers. [...]
